Press Digest: Wall Street Journal - May 18

Bio-Rad Laboratories

18/05/2026 07:29

May 18 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

- AstraZeneca AZN.L said on Monday it received U.S. approval for a new hypertension treatment, getting the green light to launch a drug the UK pharmaceutical company expects to generate multibillion-dollar annual sales at its peak.

- Activist Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories BIO.N and plans to push the supplier of life-science tools and diagnostics products to boost its underperforming stock price.

   - Samsung Electronics' 005930.KS management and union leaders resumed talks on Monday in a last-minute effort to avert a potentially disruptive strike at the world's largest memory-chipmaker.

- China said it had agreed with the U.S. to establish bilateral boards of trade and investment, fulfilling one expected outcome of U.S. President Donald Trump's visit to Beijing and solidifying a commercial truce between the world's two largest economies.

 (Compiled by Bengaluru newsroom)

 ((globalnewsmonitoring@thomsonreuters.com))